Japan start-up Innophys Co. is expanding overseas in nations that have aging populations to offer its wearable exoskeleton to support heavy lifting.
Set up by Tokyo University of Science professor Hiroshi Kobayashi, Innophys Co, hopes its products will be used in the care and farm fields in Europe, China, and South Korea, where similar age-related social issues occue.
Innophys Executive Officer Masaru Yoda said that with demand for assistive suits getting greater as populations age, they have a chance at being top in the world.
The firm has a domestic market share of about 70 percent. It sold around 20,000 Muscle Suit in April 2021 since launching it in 2014.
The exoskeletons support the arms and back.
They employ artificial muscles that are composed of rubber tubes covered in nylon mesh that expand when compressed air is added, creating a strong pulling force that can help with physically demanding manual activities and lessen back strain when lifting large goods.
The suit, which is worn like a backpack, can greatly reduce stress when performing heavy factory work, caregiving, and agricultural duties. It is also a useful tool for averting potential workplace mishaps.
Each item costs about 150,000 yen and weighs about 4 kg.
In 2020, Innophys began to expand into Taiwan, Hong Kong, and Macao. Currently, the company has sales representatives in 17 nations and areas, including China, South Korea, Germany, and France.


Asia Stocks Pause as Tech Earnings, Fed Signals, and Dollar Weakness Drive Markets
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Russia Stocks End Flat as MOEX Closes Unchanged Amid Mixed Global Signals
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
South Korea Exports Surge in January on AI Chip Demand, Marking Fastest Growth in 4.5 Years
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Trump to Announce New Federal Reserve Chair Pick as Powell Replacement Looms
Indonesia Stocks Face Fragile Sentiment After MSCI Warning and Market Rout
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Neuralink Expands Brain Implant Trials with 12 Global Patients 



